Skip to content
The Policy VaultThe Policy Vault

Mavyret — Medica

Genotype 2, 3, 5, or 6 hepatitis C virus with renal impairment (eGFR < 30 mL/min or ESRD) – new start

Initial criteria

  • Patient has met the Hepatitis C – Mavyret PA for PSM Policy criteria

Approval duration

as specified in the Hepatitis C – Mavyret PA for PSM Policy